Why U.S. Flu Cases Hit Historic Lows in 2020-21

During the 2020-21 influenza season, the United States experienced an extraordinary drop in flu activity, marking the lowest levels since systematic tracking began in the late 1990s. This phenomenon, driven largely by pandemic-related behavioral changes, offers valuable lessons for respiratory disease management.

Understanding the Historic Drop in Flu Cases

In a typical year, influenza surges in fall and winter, peaking around February and causing hundreds of thousands of hospitalizations. However, the 2020-21 season defied this pattern. CDC surveillance data revealed minimal activity nationwide, with influenza barely registering on weekly FluView reports. Lynette Brammer from the CDC’s domestic influenza team described it as ‘historically low,’ with no significant outbreaks detected.

From October 1 to February 13, only 173 flu-related hospitalizations were recorded, far below any prior season since the 1990s. Pediatric deaths stood at just one, compared to 434 in the 2019-20 season, when 400,000 were hospitalized and 22,000 died overall. This near-absence of flu, represented as a flat line on CDC graphs amid rising lines from previous years, underscores the impact of external factors.

Key Drivers Behind the Flu Suppression

• Mask-Wearing and Social Distancing: Widespread adoption of face masks and distancing reduced respiratory virus transmission, including influenza.
• School and Business Closures: Remote learning and work-from-home policies limited community spread.
• Hygiene Emphasis: Increased handwashing and surface disinfection curbed viral circulation.
• Travel Restrictions: Reduced international and domestic travel prevented flu strains from seeding outbreaks.

These measures, implemented to combat COVID-19, inadvertently created a shield against flu. CDC estimates place 2020-21 flu burden well below even the mildest recent seasons, like 2011-12.

Contrasting Recent Flu Seasons: A Return to Severity

While 2020-21 was anomalously mild, the 2024-25 season marked a stark reversal, classified as high severity with record hospitalizations. Influenza activity peaked in early February 2025 at 31.6% positive tests, the highest in nine years, dominated by A(H1N1)pdm09 and A(H3N2) viruses. Cumulative hospitalization rates hit 127.1 per 100,000—double the historical median of 62.0 and exceeding COVID-19 or RSV peaks. Over 38,000 lab-confirmed cases were hospitalized through networks covering 9% of the population.

This table highlights the volatility of flu seasons post-pandemic, emphasizing the temporary nature of suppression.

Public Health Implications and Vaccination Realities

The low flu years revealed the power of non-pharmaceutical interventions (NPIs). However, as restrictions lifted, flu rebounded forcefully. Vaccination gaps exacerbated the 2024-25 burden: only 32.4% of hospitalized patients were vaccinated, with 29% missing data. Antiviral treatment reached 84.8% overall but lagged in adolescents (61.6%). Declining uptake signals a need for renewed campaigns.

Historical context from the 1918 pandemic, which killed over 550,000 in the US via H1N1, reminds us of flu’s potential devastation without modern tools. Today’s vaccines and antivirals mitigate risks, yet adherence remains key.

Lessons for Future Respiratory Virus Seasons

The 2020-21 decline proves NPIs can drastically cut flu transmission, informing strategies for flu, RSV, and COVID-19. Hybrid approaches—combining vaccines, masks in high-risk settings, and rapid testing—could optimize protection. Public health messaging must address vaccine hesitancy, especially among youth.

Post-2025 data shows activity returning to interseasonal lows by August, but vigilance is essential. Enhanced surveillance, like CDC’s FluView, will track emerging threats.

Frequently Asked Questions

Why were flu cases so low in 2020-21?

COVID-19 precautions like masks, distancing, and closures suppressed influenza spread effectively.

Has flu returned to normal levels?

Yes, the 2024-25 season was severe, with record hospitalizations, indicating a return to typical variability.

Are flu vaccines still necessary after low seasons?

Absolutely; low prior activity doesn’t predict future mildness, and vaccines reduce severe outcomes.

How does flu compare to COVID-19 historically?

Both are respiratory threats, but 2020-21 NPIs hit flu harder due to its seasonality and transmission dynamics.

What can families do to prepare?

Vaccinate annually, practice hygiene, and monitor symptoms for early antiviral use.

Broader Historical Perspective on Influenza

Influenza has shaped public health for centuries. The 1918-1920 pandemic, caused by H1N1, prompted closures of schools, theaters, and public spaces, with mask mandates in cities like San Francisco. These early NPIs mirror 2020 strategies, validating their efficacy. Modern surveillance and vaccines represent progress, yet seasonal unpredictability persists.

From mild to severe swings, flu seasons underscore preparedness. The 2020-21 anomaly wasn’t luck but a direct result of collective action—a blueprint for resilience.